Cardinal Health has formed an agreement with GlucoTec to explore the use of GlucoTec’s proprietary technology with tje Alaris System line of intravenous pumps to help improve the control of glucose levels in patients with hyperglycemia.
GlucoTec produces the Glucommander Plus (G+) glucose management system, which uses a intravenous insulin dosing algorithm to control hyperglycemia in hospital patients, while minimizing the risk of hypoglycemia, according to the Dublin, Ohio-based Cardinal.
The Greenville, S.C.-based GlucoTec said its G+ system operates through a computer at the bedside where a clinician sets the safe target glucose range for the individual patient. As glucose measurements are entered into the system, a corresponding insulin dose recommendation is calculated and then given to the patient. The insulin dose calculation is adaptive and based on many variables, including the patient’s response to previous doses. The system also provides many safety alarms and reminders for subsequent glucose checks, according to the company.